BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36538729)

  • 1. Ugi Bis-Amide Derivatives as Tyrosinase Inhibitor; Synthesis, Biology Assessment, and in Silico Analysis.
    Yousefnejad F; Iraji A; Sabourian R; Moazzam A; Tasharoie S; Sara Mirfazli S; Zomorodian K; Alireza Akhlagh S; Hosseini S; Larijani B; Tehrani MB; Hajimahmoodi M; Mahdavi M
    Chem Biodivers; 2023 Jan; 20(1):e202200607. PubMed ID: 36538729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
    Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
    Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives.
    Rafiq M; Nazir Y; Ashraf Z; Rafique H; Afzal S; Mumtaz A; Hassan M; Ali A; Afzal K; Yousuf MR; Saleem M; Kotwica-Mojzych K; Mojzych M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-11. PubMed ID: 31456445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors.
    Hajimiri M; Khosravikia M; Khoshneviszadeh M; Pedrood K; Hosseini SZ; Asgari MS; Pirhadi S; Attarroshan M; Mobaraki K; Hosseini S; Behnammanesh H; Biglar M; Karimian S; Rastegar H; Hamedifar H; Larijani B; Mahdavi M; Iraji A
    Chem Biodivers; 2022 Jul; 19(7):e202100964. PubMed ID: 35675562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.
    Ashraf Z; Rafiq M; Nadeem H; Hassan M; Afzal S; Waseem M; Afzal K; Latip J
    PLoS One; 2017; 12(5):e0178069. PubMed ID: 28542395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives.
    Karakaya G; Türe A; Ercan A; Öncül S; Aytemir MD
    Bioorg Chem; 2019 Jul; 88():102950. PubMed ID: 31075740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors.
    Alizadeh N; Hossein Sayahi M; Iraji A; Yazzaf R; Moazzam A; Mobaraki K; Adib M; Attarroshan M; Larijani B; Rastegar H; Khoshneviszadeh M; Mahdavi M
    Bioorg Chem; 2022 Sep; 126():105876. PubMed ID: 35623142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking, Synthesis, and Tyrosinase Inhibition Activity of Acetophenone Amide: Potential Inhibitor of Melanogenesis.
    Nazir Y; Rafique H; Roshan S; Shamas S; Ashraf Z; Rafiq M; Tahir T; Qureshi ZU; Aslam A; Asad MHHB
    Biomed Res Int; 2022; 2022():1040693. PubMed ID: 35059457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel pyrimidine derivatives as a new class of mushroom tyrosinase inhibitor.
    Mirmortazavi SS; Farvandi M; Ghafouri H; Mohammadi A; Shourian M
    Drug Des Devel Ther; 2019; 13():2169-2178. PubMed ID: 31371919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties.
    Noori M; Sabourian R; Tasharoie A; Safavi M; Iraji A; Khalili Ghomi M; Dastyafteh N; Irajie C; Zarenezhad E; Mostafavi Pour SM; Rasekh F; Larijani B; Amini M; Hajimahmoodi M; Mahdavi M
    Sci Rep; 2023 Feb; 13(1):2578. PubMed ID: 36782003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
    Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, in Vitro, and in Silico Evaluation of N-Phenylacetamide-Oxindole-Thiosemicarbazide Hybrids as New Potential Tyrosinase Inhibitors.
    Yari Boroujeni S; Haghighijoo Z; Mohammadi-Khanaposhtani M; Mosadeghkhah A; Moazzam A; Yavari A; Hajimahmoodi M; Sabourian R; Hosseini S; Larijani B; Hamedifar H; Ansari S; Mahdavi M
    Chem Biodivers; 2022 Apr; 19(4):e202100666. PubMed ID: 35156774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase.
    Ashraf Z; Rafiq M; Seo SY; Kwon KS; Babar MM; Zaidi NU
    Eur J Med Chem; 2015 Jun; 98():203-11. PubMed ID: 26025140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring 3-hydroxyflavone scaffolds as mushroom tyrosinase inhibitors: synthesis, X-ray crystallography, antimicrobial, fluorescence behaviour, structure-activity relationship and molecular modelling studies.
    Ashraf J; Mughal EU; Sadiq A; Bibi M; Naeem N; Ali A; Massadaq A; Fatima N; Javid A; Zafar MN; Khan BA; Nazar MF; Mumtaz A; Tahir MN; Mirzaei M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7107-7122. PubMed ID: 32799758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel morpholine containing cinnamoyl amides as potent tyrosinase inhibitors.
    Ghafary S; Ranjbar S; Larijani B; Amini M; Biglar M; Mahdavi M; Bakhshaei M; Khoshneviszadeh M; Sakhteman A; Khoshneviszadeh M
    Int J Biol Macromol; 2019 Aug; 135():978-985. PubMed ID: 31150673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel C-2 symmetric Bis-Azo-Azamethine molecules as competitive inhibitors of mushroom tyrosinase and free radical scavengers: synthesis, kinetics, and molecular docking studies.
    Saeed A; Ahmed A; Ali Channar P; Shabir G; Hassan A; Zia-Ur-Rehman ; Abbas Q; Hassan M; Raza H; Seo SY; El-Seedi HR
    J Biomol Struct Dyn; 2022 Jul; 40(10):4419-4428. PubMed ID: 33342351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, spectroscopic characterization, in vitro tyrosinase inhibition, antioxidant evaluation, in silico and kinetic studies of substituted indole-carbohydrazides.
    Iraji A; Sheikhi N; Attarroshan M; Reaz Sharifi Ardani G; Kabiri M; Naghibi Bafghi A; Kobarfard F; Rezaei Z; Khoshneviszadeh M; Foroumadi A; Mirfazli SS
    Bioorg Chem; 2022 Dec; 129():106140. PubMed ID: 36150231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study.
    Bagheri A; Moradi S; Iraji A; Mahdavi M
    Sci Rep; 2024 Jan; 14(1):1540. PubMed ID: 38233558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.